These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12798170)

  • 1. Simultaneous determination of gemcitabine and its metabolite in human plasma by high-performance liquid chromatography.
    Yilmaz B; Kadioğlu YY; Aksoy Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):103-9. PubMed ID: 12798170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of the anticancer agent gemcitabine and its deaminated metabolite at low concentrations in human plasma by liquid chromatography-mass spectrometry.
    Xu Y; Keith B; Grem JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 802(2):263-70. PubMed ID: 15018786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of gemcitabine and its metabolite in human plasma using high-pressure liquid chromatography coupled with a diode array detector.
    Lin NM; Zeng S; Ma SL; Fan Y; Zhong HJ; Fang L
    Acta Pharmacol Sin; 2004 Dec; 25(12):1584-9. PubMed ID: 15569401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.
    Marangon E; Sala F; Caffo O; Galligioni E; D'Incalci M; Zucchetti M
    J Mass Spectrom; 2008 Feb; 43(2):216-23. PubMed ID: 17941128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2', 2'-difluorodeoxyuridine in rat plasma by UFLC-MS/MS.
    Sun Y; Zhen L; Peng Y; Wang J; Fei F; Aa L; Jiang W; Pei X; Lu L; Liu J; Wang G; Hao K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1084():4-13. PubMed ID: 29558739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in human plasma by liquid chromatography.
    Yilmaz B; Kadioğlu YY; Aksoy Y
    Anal Biochem; 2004 Sep; 332(2):234-7. PubMed ID: 15325290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the anti-cancer agent gemcitabine in human plasma by high-performance liquid chromatography.
    Keith B; Xu Y; Grem JL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 785(1):65-72. PubMed ID: 12535839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LC-MS/MS method for quantitation of gemcitabine and its metabolite 2',2'-difluoro-2'-deoxyuridine in mouse plasma and brain tissue: Application to a preclinical pharmacokinetic study.
    Zhong B; Gibson EG; Davis A; Roussel MF; Stewart CF
    J Pharm Biomed Anal; 2021 May; 198():114025. PubMed ID: 33744463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of gemcitabine and 2',2'-difluorodeoxyuridine in a patient with ascites.
    Delauter BJ; Ramanathan RK; Egorin MJ; Stover LL; Zuhowski EG; Plunkett W; Zamboni WC
    Pharmacotherapy; 2000 Oct; 20(10):1204-7. PubMed ID: 11034044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validated assays for the determination of gemcitabine in human plasma and urine using high-performance liquid chromatography with ultraviolet detection.
    Freeman KB; Anliker S; Hamilton M; Osborne D; Dhahir PH; Nelson R; Allerheiligen SR
    J Chromatogr B Biomed Appl; 1995 Mar; 665(1):171-81. PubMed ID: 7795789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates.
    Kerr JZ; Berg SL; Dauser R; Nuchtern J; Egorin MJ; McGuffey L; Aleksic A; Blaney S
    Cancer Chemother Pharmacol; 2001 May; 47(5):411-4. PubMed ID: 11391856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-performance liquid chromatographic method for the determination of gemcitabine and 2',2'-difluorodeoxyuridine in plasma and tissue culture media.
    Kirstein MN; Hassan I; Guire DE; Weller DR; Dagit JW; Fisher JE; Remmel RP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 835(1-2):136-42. PubMed ID: 16584929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2',2'-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.
    Vainchtein LD; Rosing H; Thijssen B; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2007; 21(14):2312-22. PubMed ID: 17577879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas.
    Gamblin TC; Egorin MJ; Zuhowski EG; Lagattuta TF; Herscher LL; Russo A; Libutti SK; Alexander HR; Dedrick RL; Bartlett DL
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):647-53. PubMed ID: 18040687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid determination of gemcitabine in plasma and serum using reversed-phase HPLC.
    Lanz C; Früh M; Thormann W; Cerny T; Lauterburg BH
    J Sep Sci; 2007 Aug; 30(12):1811-20. PubMed ID: 17638352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of plasma concentration of gemcitabine and its metabolite dFdU in hemodialysis patients with advanced urothelial cancer.
    Masumori N; Kunishima Y; Hirobe M; Takeuchi M; Takayanagi A; Tsukamoto T; Itoh T
    Jpn J Clin Oncol; 2008 Mar; 38(3):182-5. PubMed ID: 18270381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic study to optimize the intravesical administration of gemcitabine.
    Gontero P; Cattel L; Paone TC; Milla P; Berta G; Fiorito C; Carbone F; Medana C; Tizzani A
    BJU Int; 2010 Dec; 106(11):1652-6. PubMed ID: 20590553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of gemcitabine and its metabolite in extracellular fluid of rat brain tumor by ultra performance liquid chromatography-tandem mass spectrometry using microdialysis sampling after intralesional chemotherapy.
    Sun Y; Tang D; Chen H; Zhang F; Fan B; Zhang B; Fang S; Lu Q; Wei Y; Yin J; Yin X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():10-9. PubMed ID: 23396113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sensitive assay employing column switching chromatography to enable simultaneous quantification of an amide prodrug of gemcitabine (LY2334737), gemcitabine, and its metabolite dFdU in human plasma by LC-MS/MS.
    Wickremsinhe ER; Lee LB; Schmalz CA; Torchia J; Ruterbories KJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():117-22. PubMed ID: 23831704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasma.
    Khoury H; Deroussent A; Reddy LH; Couvreur P; Vassal G; Paci A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):71-8. PubMed ID: 17851141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.